TrialPharmacological reports : PR2022

Effects of L-carnitine supplementation in patients with mild-to-moderate COVID-19 disease: a pilot study.

Seyed Saman Talebi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.